Marinus Pharmaceuticals, Inc. announced it raised $1.23 Million in an initial filing from an offering of $1.23 Million
Apr 04, 2022•over 3 years ago
Amount Raised
$1.23 Million
Round Type
seed
RadnorHealthcare
Company Information
Company
MARINUS PHARMACEUTICALS, INC.
Location
5 Radnor Corporate Center, Suite 500
Radnor, Pennsylvania, United States
About
Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, offering a new mechanism of action with demonstrated safety and convenient dosing for patients affected by epilepsy and CNS disorders.
Radnor